TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19014839

Group type: EXPERIMENTAL
Intervention: Test formulation of lamotrigine (100 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation of lamotrigine (100 mg)
Number of subjects: 24
Study: 16650416

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate challenge test (CCCT)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Exogenous FSH ovarian reserve test (EFORT)
Number of subjects: 110
Study: 14675880

Group type: EXPERIMENTAL
Intervention: Bisoprolol 1.25 mg (increased to a maximum dose of 5 mg per day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (standard therapy with diuretic and ACE inhibitor)
Number of subjects: 52
Study: 12434619

Group type: EXPERIMENTAL
Intervention: 15% in-office hydrogen peroxide tooth-whitening touch-up agent
Number of subjects: 0
Study: 10336103

Group type: EXPERIMENTAL
Intervention: Exercise-focused maintenance program
Number of subjects: 67

Group type: COMPARATOR
Intervention: Weight-focused maintenance program
Number of subjects: 67
Study: 7863762

Group type: EXPERIMENTAL
Intervention: PCA resurfacing
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tricon stem
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tricon-M prosthesis
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tricon groups
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Unstable group (one third of patients)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Stable group (two thirds of patients)
Number of subjects: 45
Study: 1828225

Group type: EXPERIMENTAL
Intervention: Monophasic combined oral contraceptive (130 micrograms ethinylestradiol + 150 micrograms desorgestrel)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Triphasic combined oral contraceptive (30 micrograms ethinylestradiol + 50 micrograms levonorgestrel for 6 days, followed by 40 micrograms ethinylestradiol + 75 micrograms levonorgestrel for 5 days and 30 micrograms ethinylestradiol + 125 micrograms levonorgestrel for 10 days)
Number of subjects: 20
Study: 6123122

Group type: EXPERIMENTAL
Intervention: 5 or 10 mg mepindolol
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 10 mg mepindolol
Number of subjects: 104
Study: 31292969

Group type: EXPERIMENTAL
Intervention: High-dose tablets (LF 60 mg/d, LPO 7.8 mg/d)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low-dose tablets (LF 20 mg/d, LPO 2.6 mg/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 150
Study: 27662341

Group type: EXPERIMENTAL
Intervention: Lycopene-rich tomato nutrient complex (TNC)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Lutein
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 27308645

Group type: EXPERIMENTAL
Intervention: Curcumin and Fennel Essential Oil (CU-FEO)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 24467256

Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 34

Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 34
Study: 22751469

Group type: EXPERIMENTAL
Intervention: Clip-assisted tube placement
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard tube placement
Number of subjects: 143
Study: 19150955

Group type: EXPERIMENTAL
Intervention: First-line combination therapy with capecitabine and irinotecan (specific dosage and duration not mentioned)
Number of subjects: 32
Study: 17766316

Group type: EXPERIMENTAL
Intervention: Laboratory stressor task
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control manipulation
Number of subjects: 44
Study: 15076791

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (200 mg.wk(‐1), intramuscularly)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 12230027

Group type: EXPERIMENTAL
Intervention: Leaving needle (LN) acupuncture stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sparrow pecking method (SPM) acupuncture stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture (general)
Number of subjects: 0
Study: 9847429

Group type: EXPERIMENTAL
Intervention: Budesonide aqueous nasal spray, 256 microgram
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous suspension, 200 microgram
Number of subjects: 273

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study: 8021907

Group type: EXPERIMENTAL
Intervention: Propranolol (40-120 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Verapamil (80-200 mg)
Number of subjects: 30
Study: 2640054

Group type: EXPERIMENTAL
Intervention: FDP 20 g
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 811471

Group type: EXPERIMENTAL
Intervention: 30 mug TRH (single injection)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 30 mug TRH (six injections with 30 minutes interval)
Number of subjects: 4
Study: 31927662

Group type: EXPERIMENTAL
Intervention: Combined intervention groups (n=244 bakers)
Number of subjects: 337
Study: 29665158

Group type: EXPERIMENTAL
Intervention: Gastrointestinal delivery oral immunotherapy (GIDOIT) with peanut capsules, 2 to 400 mg of peanut protein daily for 24 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GIDOIT
Number of subjects: 30
Study: 26667929

Group type: EXPERIMENTAL
Intervention: Stable resistance training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Unstable resistance training
Number of subjects: 21
Study: 24445356

Group type: EXPERIMENTAL
Intervention: Vitamin K1 injection in the Spleen‐6 (SP‐6) acupuncture point
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline injection in a nonacupuncture point
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vitamin K1 injection
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Injection therapy
Number of subjects: 14
Study: 22573418

Group type: EXPERIMENTAL
Intervention: Telephone interpersonal counseling (TIP-C)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Telephone health education (THE)
Number of subjects: 140
Study: 20855910

Group type: EXPERIMENTAL
Intervention: four-layer compression bandage
Number of subjects: 12

Group type: COMPARATOR
Intervention: short-stretch compression bandage
Number of subjects: 12
Study: 19025267

Group type: EXPERIMENTAL
Intervention: Cigarette craving (hot state)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Satiated state (cold state)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hungry dieters (hot state)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Satiated dieters (cold state)
Number of subjects: 0
Study: 16469108

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (dietary energy restriction and aerobic exercise training)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal care control group
Number of subjects: 100
Study: 12566870

Group type: EXPERIMENTAL
Intervention: Timoptol XE
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Lizmon TG
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both Timoptol XE and Lizmon TG
Number of subjects: 37
Study: 10646284

Group type: EXPERIMENTAL
Intervention: Inverse filtering (Kalman and Wiener filters) of the voice signal to estimate the residue and extract seven acoustic features.
Number of subjects: 0
Study: 9543660

Group type: EXPERIMENTAL
Intervention: Alcoholic couples (female alcoholics with nonalcoholic spouses) in no-drink sessions
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Concordant couples (both spouses alcoholic)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: All alcoholic groups
Number of subjects: 131

Group type: COMPARATOR
Intervention: Couples with male alcoholics
Number of subjects: 131
Study: 8367870

Group type: EXPERIMENTAL
Intervention: Combined perioperative infusion of nifedipine (10 micrograms/kg/h) and metoprolol (12 micrograms/kg/h)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nifedipine only
Number of subjects: 70
Study: 3492644

Group type: EXPERIMENTAL
Intervention: Perioperative electrical calf stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacological methods
Number of subjects: 0
Study: 2558882

Group type: EXPERIMENTAL
Intervention: Meals with added table salt (4.25 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Meals without added table salt
Number of subjects: 10
Study: 31393628

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT)
Number of subjects: 12
Study: 31268183

Group type: EXPERIMENTAL
Intervention: Internet-based Healthy Body Image (HBI) Program
Number of subjects: 4894

Group type: EXPERIMENTAL
Intervention: Screening results
Number of subjects: 4894

Group type: EXPERIMENTAL
Intervention: HBI Program
Number of subjects: 4894
Study: 27467589

Group type: EXPERIMENTAL
Intervention: Valencia model of waking hypnosis plus cognitive‐behavioral therapy (VMWH‐CBT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Education control intervention
Number of subjects: 44
Study: 26050076

Group type: EXPERIMENTAL
Intervention: Intermittent walking (three 2-minute walking bouts)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Continuous walking (6 uninterrupted minutes)
Number of subjects: 27
Study: 23932862

Group type: EXPERIMENTAL
Intervention: Biolimus‐A9‐eluting stents (BES)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sirolimus‐eluting stents (SES)
Number of subjects: 60
Study: 22144044

Group type: EXPERIMENTAL
Intervention: High-saturated fatty acid (HSFA) diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (HMUFA) diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with n-3 polyunsaturated fatty acids (LFHCC n-3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat, high-complex carbohydrate diet supplemented with placebo (LFHCC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 0
Study: 19656558

Group type: EXPERIMENTAL
Intervention: Induction of labour
Number of subjects: 756

Group type: COMPARATOR
Intervention: Expectant monitoring
Number of subjects: 756
Study: 16915107

Group type: EXPERIMENTAL
Intervention: Albumin administration (300 mL of 20% albumin solution on the first day, then 200 mL/day if serum albumin <31 g/dL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no albumin administration)
Number of subjects: 100
Study: 12419083

Group type: EXPERIMENTAL
Intervention: Intranasal estradiol 150 microg/day
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Intranasal estradiol 300 microg/day
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 10599387

Group type: EXPERIMENTAL
Intervention: Tretinoin cream 0.1% applied every evening and hydroquinone lotion 3% applied every morning
Number of subjects: 0
Study: 7782660

Group type: EXPERIMENTAL
Intervention: Noninvasive blood pressure measurement using NCAT N-500 (oscillometrically calibrated tonometric blood pressure)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intra-arterial blood pressure (IBP) measurements
Number of subjects: 15
Study: 1777832

Group type: EXPERIMENTAL
Intervention: Budesonide, 200 micrograms once daily in each nostril
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7471617

Group type: EXPERIMENTAL
Intervention: Isoproterenol 200 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terbutaline 500 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31240995

Group type: EXPERIMENTAL
Intervention: BUD/FORM plus I+T (160/4.5 µg; two inhalations twice daily via Turbuhaler®) + I (20 µg per inhalation, two inhalations four times daily) + T (100 mg bid)
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: BUD/FORM plus I+T
Number of subjects: 584

Group type: COMPARATOR
Intervention: I+T alone
Number of subjects: 584
Study: 28540802

Group type: EXPERIMENTAL
Intervention: Embolisation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Without embolisation
Number of subjects: 73
Study: 26281342

Group type: EXPERIMENTAL
Intervention: Wound infiltration with 4 mg of lornoxicam
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 80
Study: 23569014

Group type: EXPERIMENTAL
Intervention: 0.12% ropivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 0.14% ropivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 0.16% ropivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 0.18% ropivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 0.20% ropivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 0.22% ropivacaine
Number of subjects: 105

Group type: COMPARATOR
Intervention: 0.50% ropivacaine
Number of subjects: 105
Study: 22032053

Group type: EXPERIMENTAL
Intervention: Early atropine-dobutamine stress echocardiography (EA-DSE); atropine started at dobutamine infusion rate of 20 microg/kg/min, max dose 2.0 mg.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional atropine-dobutamine stress echocardiography (CA-DSE);
Number of subjects: 100
Study: 18617640

Group type: EXPERIMENTAL
Intervention: Episodic antiretroviral therapy
Number of subjects: 5472

Group type: COMPARATOR
Intervention: Continuous antiretroviral therapy
Number of subjects: 5472

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 5472

Group type: EXPERIMENTAL
Intervention: Current smokers on continuous HIV treatment
Number of subjects: 5472

Group type: EXPERIMENTAL
Intervention: Past history of smoking
Number of subjects: 5472
Study: 16598529

Group type: EXPERIMENTAL
Intervention: Method B (right heart catheterization-derived stroke volume)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Method C (cardiovascular magnetic resonance-derived stroke volume)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both methods (B and C)
Number of subjects: 20
Study: 12554989

Group type: EXPERIMENTAL
Intervention: Endometrial cryoablation
Number of subjects: 279

Group type: COMPARATOR
Intervention: Rollerball electroablation
Number of subjects: 279
Study: 10927136

Group type: EXPERIMENTAL
Intervention: Pento+RT (Pentoxifylline + Radiotherapy)
Number of subjects: 47

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Pento+RT
Number of subjects: 47
Study: 8617898

Group type: EXPERIMENTAL
Intervention: Geriatric case-finding and liaison service
Number of subjects: 385
Study: 1623866

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prostacyclin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dihydralazine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 8
Study: 6241564

Group type: EXPERIMENTAL
Intervention: Mitral valve surgery with left atrial enlargement (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 80
Study: 30180779

Group type: EXPERIMENTAL
Intervention: HuCNS‐SC transplantation (40,000,000 cells)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 12
Study: 30129426

Group type: EXPERIMENTAL
Intervention: Nimotuzumab
Number of subjects: 0
Study: 26987315

Group type: EXPERIMENTAL
Intervention: Unified protocol combined with treatment-as-usual
Number of subjects: 54

Group type: COMPARATOR
Intervention: Waiting-list with treatment-as-usual
Number of subjects: 54
Study: 25609654

Group type: EXPERIMENTAL
Intervention: Probiotics (10^9 cfu Bifobacterium bifidum A218, 10^9 cfu Bifobacterium catenulatum A302, 10^9 cfu Bifobacterium longum A101, 10^9 cfu Lactobacillus plantarum A87 daily for six months)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (maltodextrin capsules for six months)
Number of subjects: 39
Study: 23532298

Group type: EXPERIMENTAL
Intervention: SMBG (n = 65)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: SMBG + supervised exercise (n = 65)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Combined SMBG groups (Ia + Ib)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group (HbA1c-based treatment, n = 65)
Number of subjects: 195
Study: 19487059

Group type: EXPERIMENTAL
Intervention: Tissue-engineered bone grafts
Number of subjects: 35

Group type: COMPARATOR
Intervention: Autologous bone
Number of subjects: 35
Study: 18991077

Group type: EXPERIMENTAL
Intervention: 1 mg oral micronized estradiol therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2 mg oral micronized estradiol therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16842669

Group type: EXPERIMENTAL
Intervention: IL‐6/‐572C/G genotype
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: CG genotype
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: GG genotype
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: IL‐6/‐572 C/G polymorphism
Number of subjects: 505

Group type: COMPARATOR
Intervention: Serum IL‐6 levels
Number of subjects: 505
Study: 14640800

Group type: EXPERIMENTAL
Intervention: Cohesive families
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Triangulated families
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Changes in family functioning
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Separate families
Number of subjects: 57
Study: 11099596

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Age over 12 months
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: History of wheezing
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis on study entry
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Skin prick test positivity at 16 months
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Furred pet sensitization
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: RSV identification
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Early furred pet contact at home
Number of subjects: 89
Study: 9089901

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (5.2 g of concentrated fish oil triglyceride, 1.60 g/day EPA and 1.04 g/day DHA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (5.2 g corn oil)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 1610257

Group type: EXPERIMENTAL
Intervention: St. Jude mitral valve prosthesis
Number of subjects: 102

Group type: COMPARATOR
Intervention: Medtronic-Hall mitral valve prosthesis
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both prostheses
Number of subjects: 102
Study: 3889758

Group type: EXPERIMENTAL
Intervention: Immediate intensive remission induction using Daunomycin and Cytosine Arabinoside (branch I)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Supportive care, 'wait and see' policy, and palliative cytoreduction with Hydroxyurea and Ara C when necessary (branch II)
Number of subjects: 27
Study: 31160171

Group type: EXPERIMENTAL
Intervention: Ribociclib 600 mg/d (3 weeks on/1 week off) with letrozole 2.5 mg/d (continuous)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo with letrozole
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 29102285

Group type: EXPERIMENTAL
Intervention: Arterectomy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Myectomy alone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Myectomy and foraminotomy/fasciotomy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Myectomy and arterectomy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Foraminotomy/fasciotomy alone
Number of subjects: 13
Study: 26632082

Group type: EXPERIMENTAL
Intervention: Single oral dose of guaifenesin (age‐based doses of 100‐400 mg)
Number of subjects: 40
Study: 24351572

Group type: EXPERIMENTAL
Intervention: Nonpreserved methylprednisolone 1% (group A)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Preserved prednisolone 1% (group B)
Number of subjects: 68
Study: 22817381

Group type: EXPERIMENTAL
Intervention: Preprocedural ventricular rate during AF (lowest quartile)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Low preprocedural ventricular rate during AF
Number of subjects: 102
Study: 20013603

Group type: EXPERIMENTAL
Intervention: Gum chewing (group G, N = 193)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Control group (group C, N = 195)
Number of subjects: 388
Study: 18667293

Group type: EXPERIMENTAL
Intervention: Behavior therapy for 12 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 11
Study: 16248238

Group type: EXPERIMENTAL
Intervention: Compound Danshen Droplet‐pill (DS) combined with trimetazidine (TMZ)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) alone (Control group)
Number of subjects: 120
Study: 12587807

Group type: EXPERIMENTAL
Intervention: Tiotropium bromide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ipratropium bromide
Number of subjects: 0
Study: 10554442

Group type: EXPERIMENTAL
Intervention: Party blower intervention
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pinwheel intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (standard instructions)
Number of subjects: 80
Study: 8277091

Group type: EXPERIMENTAL
Intervention: Sulodexide (600 LRU intramuscular injection for 1 month, followed by 500 LRU oral capsules twice daily)
Number of subjects: 3986
Study: 2657423

Group type: EXPERIMENTAL
Intervention: 42-day dexamethasone (n = 13)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 18-day dexamethasone (n = 12)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 36
Study: 1187285

Group type: EXPERIMENTAL
Intervention: 8 mg/kg oral dose of a new xanthone drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as part of double-blind design)
Number of subjects: 0
Study: 31036422

Group type: EXPERIMENTAL
Intervention: Bone channeling
Number of subjects: 23

Group type: COMPARATOR
Intervention: No channeling
Number of subjects: 23